The Colon Health and Life-Long Exercise Change Trial: A Randomized Trial of the National Cancer Institute of Canada Clinical Trials Group
Kerry S. Courneya(University of Alberta), Ralph M. Meyer(Queen's University), Dongsheng Tu(Ontario Institute for Cancer Research), Sharlene Gill(Deventer Ziekenhuis), M.D. Brundage(Queen's University), Christopher M. Booth(Queen's University), Peter J. O’Brien(Queen's University), H. Dhillon(The University of Sydney), Christine M. Friedenreich(University of Calgary), H. Au(Ontario Institute for Cancer Research), Janette L. Vardy(The University of Sydney)
Cited by 176
Related Papers
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
|Journal of Clinical Oncology|2007|3.9k
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k
Cetuximab for the Treatment of Colorectal Cancer
|New England Journal of Medicine|2007|1.8k